Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: HAWAII BIOTECH, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-07-05 to 2025-07-05
Current total value of award: $2997218
Description: RECOMBINANT WEST NILE VIRUS VACCINE ADJUVANTED WITH SLA-LSQ